Clinical Trial

An Antibody-armored Dendritic Cell in Patients With Solid Tumors

Name: An Antibody-armored Dendritic Cell in Patients With Solid Tumors — clinical trial record (NCT07479667)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: dendritic cell

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a single-arm, open-label, single-administration dose-escalation study.

Trial Details

NCT Number	NCT07479667
Lead Sponsor	Shanghai Cell Therapy Group Co.,Ltd
Conditions	Solid Cancers, Adjuvant Therapy
Enrollment	8 participants
Start Date	2026-02-05
Primary Completion	2028-12-31 (estimated)
Study Completion	2029-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-18